CONMED Corporation
CNMD | NYSE
$45.49
+$0.80 (+1.79%)
Sep 22, 2026, 10:40 AM ET · Market open
Company Profile
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.
Key Executives
| Name | Position |
|---|---|
| Patrick J. Beyer | President, Chief Executive Officer & Director |
| Richard Glaze | Chief Information Officer |
| Brent Lalomia | Executive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations & IT |
| Curt R. Hartman | Special Advisor |
| David R. Murray | President of ConMed Electrosurgery |
| Hollie Foust | Executive Vice President, General Counsel and Corporate Secretary |
| John E. Gallagher | Executive VP, CFO and Principal Financial & Accounting Officer |
| John Ferrell | Executive Vice President of Human Resources |
| Johonna Marie Pelletier | Vice President of Tax & Treasurer |
| Josep Lluis Llorens | Executive VP Global Supply Chain Management & Operations |
| Keith Seaton | Vice President of Compliance |
| Kimberly A. Lockwood | Interim Corporate Controller & Interim Principal Accounting Officer |
| Peter K. Shagory | Executive Vice President of Strategy & Corporate Development |
| Todd W. Garner | Advisor |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 17, 2026 | 4 | Filing |
| Jul 17, 2026 | 3 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 3 | Filing |
| Jul 02, 2026 | 3 | Filing |
| Jun 17, 2026 | 8-K | Current Report |
| Jun 16, 2026 | 11-K | Filing |
CONMED Corporation
| Country | United States |
| IPO Date | Jul 22, 1987 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 3,900 |
| CEO | Patrick J. Beyer |
Contact Details
11311 Concept Boulevard Largo,
Florida 33773 United States
Stock Details
| Ticker Symbol | CNMD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000816956 |
| CUSIP Number | 207410101 |
| ISIN Number | US2074101013 |
| SIC Code | 3845 |
Recent News
- 6 days ago / zacks.comHere's Why You Should Retain CONMED Stock in Your Portfolio for Now
- 25 days ago / zacks.comConmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
- 27 days ago / businesswire.comCONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
- 1 month ago / seekingalpha.comCONMED Corporation: Organic Growth Is Masked By Divestitures
- 1 month ago / zacks.comCNMD Jumps 16% in a Month as Investors Assess Whether It Can Last
- 1 month ago / zacks.comCan CONMED's Raised 2026 EPS Outlook Reinforce Its Growth Momentum?
- 1 month ago / zacks.comIs CNMD a Buy Now as Low Valuation Meets Persistent Execution Risk?
- 1 month ago / zacks.comHere's Why You Should Retain CONMED Stock in Your Portfolio Now
- 2 months ago / zacks.comCONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
- 2 months ago / seekingalpha.comCONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
Add to Watchlist
Select watchlists to add or remove CNMD